![]() |
市場調查報告書
商品編碼
1423682
2030 年細胞培養皮革市場預測:按技術、應用和地區分類的全球分析Cell-Cultured Leather Market Forecasts to 2030 - Global Analysis By Technology (Collagen-based, Mycelium-based and Other Technologies), By Application (Apparel, Automotive, Footwear and Other Applications) and By Geography |
根據 Stratistics MRC 的數據,2023 年全球細胞培養皮革市場規模為 449 萬美元,預計到 2030 年將達到 940 萬美元,預測期內複合年成長率為 11.1%。
細胞培養皮革,也稱為實驗室種植或生物製造皮革,是採用細胞農業技術生產的。它模仿動物皮膚的發育過程,並涉及在受控的實驗室環境中培養動物細胞。透過這個過程,膠原蛋白和其他蛋白質被生長並組裝成具有與傳統皮革相似的特性的材料,為傳統動物皮革提供了永續的替代品。
對永續和無殘忍產品的需求不斷成長
消費者對永續性和道德實踐的認知不斷提高,推動了對細胞培養皮革的需求。隨著消費者優先考慮環保選擇,皮革產業因環境和動物福利問題而受到密切關注。細胞培養皮革透過提供無殘忍且永續的替代品來滿足這一需求。其無動物生產符合道德價值觀,吸引了尋求負責任、生態意識時尚的消費者。人們對永續和無殘忍產品的認知和偏好不斷增強,正在推動市場成長。
擴大生產面臨的挑戰
由於生物製造的複雜性,擴大生產是細胞培養皮革市場的挑戰。要實現大規模生產,同時保持產品品質和一致性,需要強大且具成本效益的生物加工技術。此外,建立高效的原料供應鏈和獲得大規模生產的監管批准已成為障礙,儘管需求不斷成長,但仍影響了市場的快速擴充性。
素食和環保意識的消費者群體不斷成長
隨著道德和永續實踐意識的不斷增強,消費者正在尋找傳統皮革的替代品。細胞培養皮革透過提供無殘忍且環保的選擇來符合這些價值觀。對最大限度地減少環境影響和對動物傷害的產品的需求不斷成長,使細胞培養皮革成為一個有吸引力的選擇。利用這一趨勢是市場成長和更廣泛採用創新和永續材料的機會。
與替代合成皮革的競爭
來自合成皮革替代品的競爭對細胞培養皮革市場構成威脅。合成皮革生產成本低,製造製程成熟。聚氨酯和 PVC 人造皮革等合成材料的進步為消費者提供了更便宜、更廣泛的選擇,從而帶來了挑戰。此外,合成皮革產業的大規模生產能力和消費者對這些材料的熟悉程度阻礙了細胞培養皮革的快速普及。
COVID-19 大流行擾亂了細胞培養皮革市場的供應鏈和投資計劃,造成了最初的挫折。然而,這場危機凸顯了對永續和有彈性的供應鏈的需求,以及對環保替代品的興趣增加。疫情期間,消費者對道德時尚和永續性的意識也大幅提升,推動了對零殘忍產品的需求增加。消費行為的這些變化最終加速了市場的復甦和細胞培養皮革的採用。
箱包業務預計將在預測期內成為最大的業務
消費者對永續和無殘忍時尚的日益偏好預計將引領箱包細分市場的發展。人們對細胞培養皮革的興趣激增,特別是隨著對環保替代品的需求增加,尤其是箱包等配件。此外,奢侈品牌與細胞培養皮革生產商之間的合作夥伴關係,旨在創造環保、高品質的產品,也進一步推動了這一領域的成長。
預計基於菌絲體的細分市場在預測期內複合年成長率最高。
由於其永續和多功能的性質,基於菌絲體的細分市場有望快速成長。菌絲體(真菌根結構)是製造細胞培養皮革的可再生資源。它能夠模仿傳統皮革的質地和特性,加上菌絲體培養技術的進步,支持了其巨大的潛力。此外,人們對環保替代品的興趣日益濃厚,以及對研發的投資,使基於菌絲體的細胞培養皮革成為領跑者,預計該細分市場的複合年成長率最高。
由於對永續性的高度重視、嚴格的監管和強勁的技術創新,歐洲地區預計將佔據最大的市場佔有率。該地區優先考慮道德和環保實踐,滿足消費者對無捲曲和環保產品的需求。廣泛的政府支持、研究投資以及學術界和工業界之間的合作正在推動技術進步。此外,奢侈時尚和汽車行業對替代材料的積極態度進一步鞏固了歐洲在塑造細胞培養皮革市場方面的主導地位。
由於技術的快速進步和傾向於永續時尚的消費者基礎的快速成長,預計亞太地區的市場將出現顯著成長。隨著紡織業的蓬勃發展和生態意識的轉變,中國、日本和韓國等國家正大力投資創新技術。此外,支持永續實踐的合作和政府措施的增加進一步增加了該地區細胞培養皮革的採用和生產大幅擴展的潛力。
According to Stratistics MRC, the Global Cell-Cultured Leather Market is accounted for $4.49 million in 2023 and is expected to reach $9.40 million by 2030 growing at a CAGR of 11.1% during the forecast period. Cell-cultured leather, also known as lab-grown or biofabricated leather is produced using cellular agriculture techniques. It involves cultivating animal cells in a controlled lab environment, mimicking the process of animal skin development. Through this process, collagen and other proteins are grown and assembled into material with characteristics similar to traditional leather, offering a sustainable and cruelty-free alternative to conventional animal-derived leather.
Rising demand for sustainable and cruelty-free products
The growing consumer consciousness towards sustainability and ethical practices propels the demand for cell-cultured leather. As consumers prioritise eco-friendly choices, the leather industry faces scrutiny due to environmental concerns and animal welfare. Cell-cultured leather, offering a cruelty-free and sustainable alternative, meets this demand. Its production without animal involvement aligns with ethical values, attracting consumers seeking responsible, eco-conscious fashion. This heightened awareness and preference for sustainable, cruelty-free products drives the market's growth.
Challenges in scaling up production
Scaling up production poses challenges in the cell-cultured leather market due to the complex nature of biomanufacturing. Achieving large-scale production while maintaining product quality and consistency demands robust and cost-effective bioprocessing techniques. Additionally, establishing efficient supply chains for raw materials and securing regulatory approvals for mass production present hurdles, impacting the market's swift scalability despite growing demand.
Growth of the vegan and eco-conscious consumer base
Owing to rising awareness of ethical and sustainable practices, consumers seek alternatives to traditional leather. Cell-cultured leather, offering a cruelty-free and eco-friendly option, aligns with these values. The growing demand for products that minimise environmental impact and animal harm positions cell-cultured leather as an attractive choice. Capitalising on this trend presents an opportune moment for market growth and wider adoption of innovative, sustainable materials.
Competition from synthetic leather alternatives
Competition from synthetic leather alternatives poses a threat to the cell-cultured leather market. Synthetic leather offers lower production costs and established manufacturing processes. Advances in synthetic materials, such as polyurethane and PVC-based faux leather, pose a challenge by providing a cheaper and more widely available option for consumers. Additionally, the synthetic leather industry's capacity for large-scale production and the familiarity of consumers with these materials hinder the rapid adoption of cell-cultured leather.
The COVID-19 pandemic disrupted supply chains and investment plans in the cell-cultured leather market, causing initial setbacks. However, the crisis underscored the need for sustainable and resilient supply chains, fueling increased interest in eco-friendly alternatives. Consumer awareness regarding ethical fashion and sustainability also surged during the pandemic, driving a heightened demand for cruelty-free products. This shift in consumer behaviour ultimately accelerated the market's recovery and adoption of cell-cultured leather.
The luggage & bags segment is expected to be the largest during the forecast period
The luggage and bags segment is anticipated to lead the market due to increasing consumer preferences for sustainable and cruelty-free fashion. As the demand for eco-friendly alternatives grows particularly in accessories like bags and luggage, there's a surge in interest in cell-cultured leather. Additionally, partnerships between luxury brands and cell-cultured leather producers to create high-quality environmentally conscious products further drive the segment's growth.
The mycelium-based segment is expected to have the highest CAGR during the forecast period
The mycelium-based segment is poised for rapid growth due to its sustainable and versatile nature. Mycelium, the root structure of fungi, serves as a renewable resource for creating cell-cultured leather. Its ability to mimic the texture and properties of traditional leather, coupled with advancements in mycelium cultivation techniques, drives its high potential. In addition, growing interest in eco-friendly alternatives, coupled with investments in research and development, positions mycelium-based cell-cultured leather as a frontrunner, projecting the segment's highest CAGR.
The European region is estimated to witness the largest market share owing to its strong focus on sustainability, stringent regulations and robust innovation. The region prioritises ethical and environmentally friendly practices, aligning with consumer demands for cruelty-free and eco-conscious products. Extensive government support, research investments and collaborations between academia and industry fuel technological advancements. Moreover, a proactive approach towards alternative materials in the luxury fashion and automotive industries further cements Europe's dominance in shaping the cell-cultured leather market.
The Asia Pacific region is primed for substantial growth in the market due to burgeoning technological advancements and a burgeoning consumer base inclined towards sustainable fashion. With a thriving textile industry and a shift towards eco-consciousness, countries like China, Japan and South Korea are investing heavily in innovative technologies. Additionally, increasing collaborations and government initiatives supporting sustainable practices further bolster the region's potential for significant expansion in cell-cultured leather adoption and production.
Key players in the market
Some of the key players in Cell-Cultured Leather Market include Biofabricate, Biomason, Bioworks, Bolt Threads, CELLINK, Geltor, Modern Meadow, Mycotech, MycoWorks, Orbillion Bio, TerViva, TextileGenesis, Tiamat Sciences, Triton Algae Innovations and VitroLabs.
In July 2023, Modern Meadow raised Series D funding. The funding is led by Astanor Ventures, Horizons Ventures, and Key Partners Capital, which will support Modern Meadow to continue its innovation.
In May 2022, VitroLabs Inc raised US$ 46 million to build and scale the world's first pilot production of cell-cultivated leather. The Series A funding is led by Agronomics; other investors include BESTSELLER's Invest FWD, global luxury group Kering, Khosla Ventures, actor and environmentalist Leonardo DiCaprio, New Agrarian, and Regeneration.VC. Moreover, Kering continues its partnership with VitroLabs Inc in bringing support for product quality testing, tanning, and finishing.